Hyperferritinemia and inflammation
- 25 May 2017
- journal article
- review article
- Published by Oxford University Press (OUP) in International Immunology
- Vol. 29 (9), 401-409
- https://doi.org/10.1093/intimm/dxx031
Abstract
Understanding of ferritin biology has traditionally centered on its role in iron storage and homeostasis, with low ferritin levels indicative of deficiency and high levels indicative of primary or secondary hemochromatosis. However, further work has shown that iron, redox biology and inflammation are inexorably linked. During infection, increased ferritin levels represent an important host defense mechanism that deprives bacterial growth of iron and protects immune cell function. It may also be protective, limiting the production of free radicals and mediating immunomodulation. Additionally, hyperferritinemia is a key acute-phase reactants, used by clinicians as an indication for therapeutic intervention, aimed at controlling inflammation in high-risk patients. One school of thought maintains that hyperferritinemia is an ‘innocent bystander’ biomarker of uncontrolled inflammation that can be used to gauge effectiveness of intervention. Other schools of thought maintain that ferritin induction could be a protective negative regulatory loop. Others maintain that ferritin is a key mediator of immune dysregulation, especially in extreme hyperferritinemia, via direct immune-suppressive and pro-inflammatory effects. There is a clear need for further investigation of the role of ferritin in uncontrolled inflammatory conditions both as a biomarker and mediator of disease because its occurrence identifies patients with high mortality risk and its resolution predicts their improved survival.Keywords
Funding Information
- National Institute of General Medical Sciences (R01GM108168)
This publication has 111 references indexed in Scilit:
- The Hyperferritinemic Syndrome: macrophage activation syndrome, Still’s disease, septic shock and catastrophic antiphospholipid syndromeBMC Medicine, 2013
- Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLHBlood, 2011
- How I treat hemophagocytic lymphohistiocytosisBlood, 2011
- Repeated TLR9 stimulation results in macrophage activation syndrome–like disease in miceJCI Insight, 2011
- Type I Interferons Protect From Toll-Like Receptor 9–Associated Liver Injury and Regulate IL-1 Receptor Antagonist in MiceGastroenterology, 2011
- Glyburide inhibits the Cryopyrin/Nalp3 inflammasomeThe Journal of cell biology, 2009
- Drug-Induced Hypersensitivity SyndromeMedicine, 2009
- Ferritin functions as a proinflammatory cytokine via iron-independent protein kinase C zeta/nuclear factor kappaB-regulated signaling in rat hepatic stellate cellsHepatology, 2008
- Hemophagocytic macrophages constitute a major compartment of heme oxygenase expression in sepsisEuropean Journal of Haematology, 2006
- Parenteral iron nephrotoxicity: Potential mechanisms and consequences1Kidney International, 2004